# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger ...
On Thursday, 109 companies set new 52-week lows.
Friday's session saw 100 companies set new 52-week lows.
On Wednesday, 345 companies set new 52-week lows.
On Monday, 76 companies set new 52-week lows.
Combined company expected to have a cash runway through Phase 2b clinical data and to the end of 2024
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic ...
LifeSci Special Opportunities Master Fund Ltd. ("LifeSci Special Opportunities" or "we"), the holder of 96,976 ...
Diffusion Pharmaceuticals (NASDAQ:DFFN) reported quarterly losses of $(1.37) per share. This is a 77.13 percent increase over l...